Zero Candida Technologies
AI-enabled Blue-light Vaginal Device for at-home VVC Treatment and Monitoring
Company Overview
Snapshot
Founded in January 2022 by Eli Ben Haroosh and Asher Holzer, Zero Candida Technologies operates with 11–50 employees. The company became public on the TSX Venture Exchange in November 2024, marking a significant corporate milestone.
Business overview
Zero Candida Technologies is a FemTech company developing an AI-enabled, tampon-like medical device designed for the at-home treatment and monitoring of Vulvo-Vaginal Candidiasis (VVC). Its core technology utilizes a controlled blue light source to target and eliminate Candida fungus without side effects. The device also collects and transmits treatment data in real-time to physicians, enabling remote care and personalized treatment. Zero Candida Technologies operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics for women.
Strategic signal
Zero Candida Technologies recently achieved a significant intellectual property milestone by being granted Patent No. 12654025B2 in June 2026. This patent grant validates the company's innovative approach to FemTech medical devices and strengthens its market position, signaling to investors a robust commitment to technological advancement and long-term impact in the healthcare industry.
Log in to access full profile ›Company Intelligence Q&A
- What was a key corporate development for Zero Candida Technologies in late 2024?
- Zero Candida Technologies announced its listing date on the TSX Venture Exchange in November 2024, transitioning to a public company status.
- What recent product development milestone did Zero Candida achieve?
- In October 2025, Zero Candida achieved design freeze and began prototype production of its ZC-001 therapeutic device.
- What was a significant operational update for Zero Candida Technologies in early 2026?
- In February 2026, Zero Candida scaled production to 250 ISO 13485 clinical-grade prototypes of its ZC-001 therapeutic device.
- What intellectual property milestone did Zero Candida Technologies achieve in June 2026?
- In June 2026, Zero Candida Technologies was officially granted Patent No. 12654025B2, reflecting its commitment to innovation and technology.
- Did Zero Candida Technologies report financial results recently?
- Yes, in September 2025, Zero Candida Technologies reported financial results for the three and six months ended June 30, 2025, and provided a business update.